Genvoya

Indicated For

HIV-1 infection

About This Medication

# Gilead Advancing Access Patient Assistance Program/Medication Assistance Program (PAP/MAP) Patient Guide: How to Get Genvoya (elvitegravir cobicistat emtricitabine tenofovir alafenamide) at Low or No Cost Genvoya is a prescription medication used to treat HIV-1 infection in adults and children, combining four antiretroviral drugs: elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide. The **Gilead Advancing Access Patient Assistance Program/Medication Assistance Program (PAP/MAP)** provides Genvoya at no cost to eligible uninsured or underinsured patients who meet specific income and residency requirements.[1][6] ## Who Qualifies for the Program? This program is designed for patients struggling to afford their HIV medication. To qualify, you must: - Be a resident of the United States, Puerto Rico, or U.S. Territories (proof of residency required).[2] - Have **household income at or below 500% of the Federal Poverty Level (FPL)** for uninsured patients.[1] - Be **uninsured or underinsured**; a separate co-pay program exists for commercially insured patients.[1][7] - Have a valid prescription for Genvoya from your healthcare provider. **Note:** Patients eligible for Medicaid or AIDS Drug Assistance Program (ADAP) may not qualify. Always confirm with the program.[2] ## About Genvoya **Genvoya** is a complete HIV treatment regimen in one pill taken once daily. It helps control the virus, reduces viral load, and supports immune system recovery. Common side effects include nausea, diarrhea, and headache, but consult your doctor for personalized advice. This program ensures access without financial barriers for those who qualify, as Genvoya is among Gilead's supported HIV medications.[6] ## Income Eligibility Breakdown Eligibility hinges on household income relative to the **Federal Poverty Level (FPL)**. The program covers uninsured patients at **≤500% FPL**. Use the table below for 2026 guidelines (FPL updates annually; verify current levels at the program or HHS.gov). | Household Size | 100% FPL | 500% FPL (Max for Eligibility) | |---------------|----------|-------------------------------| | 1 | $15,060 | $75,300 | | 2 | $20,440 | $102,200 | | 3 | $25,820 | $129,100 | | 4 | $31,200 | $156,000 | *Add ~$5,380 per additional person for 100% FPL, scaling to 500%.* Proof of income (tax returns, pay stubs) is required.[1][3] ## Insurance Requirements - **Uninsured patients**: Primary target; receive medication free if income-qualified.[1][7] - **Underinsured**: May qualify if insurance doesn't cover fully and income meets criteria. - **Commercially insured**: Use the separate Co-pay Savings Program (up to $7,200/year assistance).[8] - **Medicare/Medicaid/ADAP**: Generally ineligible for PAP/MAP; explore other options via Advancing Access.[2] Enrollment screens insurance status automatically.[3] ## Step-by-Step Application Process 1. **Discuss with your doctor**: Get a prescription for Genvoya and confirm medical need. Ask for a Letter of Medical Necessity if needed.[9] 2. **Gather documents**: - Proof of income (W-2, tax return, pay stubs). - Proof of residency (utility bill, lease). - Prescription. - Proof of insurance status (denial letter or insurance card).[1] 3. **Choose application method** (multiple options available): - **Online**: Visit GileadAdvancingAccess.com, enroll for immediate eligibility check.[1] - **Download & Fax**: Get English/Spanish form, complete with signatures, fax to number on form (reviewed in 2 business days).[1][3] - **Phone**: Call **(800) 226-2056** (Mon-Fri, 9 AM-8 PM ET) for assistance.[1][5] 4. **Sign and submit**: Patient and doctor sign; authorize info use for verification.[3] 5. **Follow up**: Program may call to confirm details.[1] ## Timeline and Delivery - **Processing**: Online may give instant decision; fax/phone reviewed in ~**2 business days**.[1][4] - **Approval duration**: Up to **12 months**, with reauthorization required.[4] - **Delivery**: Shipped free to your home via mail-order pharmacy (ARx Patient Solutions Pharmacy, effective May 5, 2025). Pharmacy calls from 1-866-930-4146.[1][4] - **Refills**: Contact program/pharmacy for ongoing supply during eligibility period.[4] ## Alternatives if Denied - **Appeal**: Provide additional documents or updated info; call (800) 226-2056.[1] - **Co-pay Program**: For insured patients.[7] - **Other resources**: Benefits investigation, prior auth help, ADAP, Medicaid, or state programs via Advancing Access.[1][2] - **Re-enroll**: Possible after enrollment ends if still eligible (not on Medicaid/ADAP).[2] - **Generic options**: No biosimilars listed; discuss alternatives with doctor.[1] ## Important Disclaimer This guide is for informational purposes based on program details as of March 2026. Eligibility, terms, and FPL change; **always verify directly with Gilead Advancing Access at (800) 226-2056 or GileadAdvancingAccess.com**. Not medical/financial advice—consult your healthcare provider. Program availability subject to change; Gilead may verify info with credit bureaus.[3] Word count: 942.

Program information last verified: March 30, 2026